Bio-Techne Corporation (TECH) Financial Statements

Bio-Techne Corporation (TECH) files with the U.S. Securities and Exchange Commission under CIK 0000842023. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2026

Revenue
$1.22 billion
Total Assets
$2.59 billion
Net Cash from Operations
$292.07 million

Fiscal year ended Jun 30, 2026. Latest periodic SEC filing: Aug 24, 2026. Source: SEC filings (EDGAR XBRL).

Open the full financial statements for TECH in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History